Oncology Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation.), By Treatment(Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation.), By Application(Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer), By Region - Industry Forecast 2024-2031

Oncology Ablation Market size was valued at USD 1.15 billion in 2022 and is poised to grow from USD 1.31 billion in 2023 to USD 3.62 billion by 2031, growing at a CAGR of 13.6% in the forecast period (2024-2031).

Growing need for safer therapeutic choices and rising incidence of cancer are two key drivers of the market expansion. In low-income nations, the number of new cancer cases is anticipated to rise by more than 80%, compared to a rate of 41% in high-income nations. The market is anticipated to increase substantially in the forecast period due to the therapeutic choices that are currently available and the rising demand for minimally invasive and non-invasive treatments.

The demand for advanced tumour ablation techniques is anticipated to increase throughout the forecast period as surgeons and patients become more inclined toward minimally invasive procedures due to the advantages of quick recovery, patient comfort, and shorter recovery times. Comparing advanced tumour ablation procedures to conventional therapies, advanced tumour ablation operations are typically conducted on an outpatient basis and do not require any hospital admission, considerably lowering the overall cost of healthcare. The preferred treatment for tumours of lesser sizes is ablative surgery. As a result, the volume of its procedures is indirectly influenced by the yearly cancer screening rates.

US Oncology Ablation Market is poised to grow at a sustainable CAGR for the next forecast year.